Oral pharmaceutical composition of lurasidone and preparation thereof
US11260055B2 · kind B2 · utility
0Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 10, 2018 |
| Grant date | Mar 1, 2022 |
| Priority date | — |
| Expiry date | Jan 10, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an oral pharmaceutical composition, particularly a tablet, comprising an active ingredient lurasidone or its pharmaceutically acceptable salt(s) or solvate(s) thereof and one or more pharmaceutical excipient(s); and a process for its preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.